Robust Optimization for Spot-Scanning Proton Therapy based on Dose-Linear-Energy-Transfer Volume Constraints

被引:2
作者
Chen, Jingyuan [1 ]
Yang, Yunze [2 ]
Feng, Hongying [1 ,3 ,4 ]
Zhang, Lian [1 ,5 ]
Liu, Zhengliang [1 ,6 ]
Liu, Tianming [6 ]
Vargas, Carlos E. [1 ]
Yu, Nathan Y. [1 ]
Rwigema, Jean-Claude M. [1 ]
Keole, Sameer R. [1 ]
Patel, Samir H. [1 ]
Vora, Sujay A. [1 ]
Shen, Jiajian [1 ]
Liu, Wei [1 ]
机构
[1] Mayo Clin, Dept Radiat Oncol, Phoenix, AZ 85054 USA
[2] Univ Miami, Dept Radiat Oncol, Miami, FL USA
[3] China Three Gorges Univ, Coll Math & Phys, Yichang, Hubei, Peoples R China
[4] Guangzhou Concord Canc Ctr, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China
[5] Hebei Med Univ, Hosp 1, Dept Oncol, Shijiazhuang, Hebei, Peoples R China
[6] Univ Georgia, Sch Comp, Athens, GA USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2025年 / 121卷 / 05期
关键词
EFFECTIVENESS RBE VALUES; BIOLOGICAL EFFECTIVENESS; RANGE UNCERTAINTIES; RADIOTHERAPY; IMPT;
D O I
10.1016/j.ijrobp.2024.11.068
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Historically, spot-scanning proton therapy (SSPT) treatment planning uses dose-volume constraints and linear- energy-transfer (LET) volume constraints separately to balance tumor control and organs-at-risk (OARs) protection. We propose a novel dose-LET-volume constraint (DLVC)-based robust optimization (DLVCRO) method for SSPT in treating prostate cancer to obtain a desirable joint dose and LET distribution to minimize adverse events. Methods and Materials: DLVCRO treats DLVC as soft constraints that control the shapes of the dose-LET volume histogram (DLVH) curves. It minimizes the overlap of high LET and high dose in OARs and redistributes high LET from OARs to targets in a user-defined way. Ten patients with prostate cancer were included in this retrospective study. Rectum and bladder were considered as OARs. DLVCRO was compared with the conventional robust optimization (RO) method. Plan robustness was quantified using the worst-case analysis method. Besides the dose-volume histogram indices, the analogous LET-volume histogram, extrabiological dose (the product of per voxel dose and LET) volume histogram (xBDVH) indices characterizing the joint dose/LET distributions and DLVH indices were also used. The Wilcoxon signed-rank test was performed to measure statistical significance. Results: In the nominal scenario, DLVCRO significantly improved joint distribution of dose and LET to protect OARs compared with RO. The physical dose distributions in targets and OARs are comparable. In the worst-case scenario, DLVCRO markedly enhanced OAR protection (more robust) while maintaining almost the same plan robustness in target dose coverage and homogeneity. Conclusions: DLVCRO upgrades 2D DVH-based to 3D DLVH-based treatment planning to adjust dose/LET distributions simultaneously and robustly. DLVCRO is potentially a powerful tool to improve patient outcomes in SSPT. (c) 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:1303 / 1315
页数:13
相关论文
共 47 条
[1]  
An Y, 2017, MED PHYS, V44, P28, DOI [10.1002/mp.12001, 10.1002/mp.12610]
[2]   Robust optimization to reduce the impact of biological effect variation from physical uncertainties in intensity-modulated proton therapy [J].
Bai, Xuemin ;
Lim, Gino ;
Grosshans, David ;
Mohan, Radhe ;
Cao, Wenhua .
PHYSICS IN MEDICINE AND BIOLOGY, 2019, 64 (02)
[3]  
Beltran Chris, 2016, Int J Part Ther, V3, P312, DOI [10.14338/ijpt-16-00011.1, 10.14338/IJPT-16-00011.1]
[4]   Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis [J].
Blanchard, Pierre ;
Garden, Adam S. ;
Gunn, G. Brandon ;
Rosenthal, David I. ;
Morrison, William H. ;
Hernandez, Mike ;
Crutison, Joseph ;
Lee, Jack J. ;
Ye, Rong ;
Fuller, C. David ;
Mohamed, Abdallah S. R. ;
Hutcheson, Kate A. ;
Holliday, Emma B. ;
Thaker, Nikhil G. ;
Sturgis, Erich M. ;
Kies, Merrill S. ;
Zhu, X. Ronald ;
Mohan, Radhe ;
Frank, Steven J. .
RADIOTHERAPY AND ONCOLOGY, 2016, 120 (01) :48-55
[5]   Linear energy transfer incorporated intensity modulated proton therapy optimization [J].
Cao, Wenhua ;
Khabazian, Azin ;
Yepes, Pablo P. ;
Lim, Gino ;
Poenisch, Falk ;
Grosshans, David R. ;
Mohan, Radhe .
PHYSICS IN MEDICINE AND BIOLOGY, 2018, 63 (01)
[6]   Clinical consequences of relative biological effectiveness variations in proton radiotherapy of the prostate, brain and liver [J].
Carabe, Alejandro ;
Espana, Samuel ;
Grassberger, Clemens ;
Paganetti, Harald .
PHYSICS IN MEDICINE AND BIOLOGY, 2013, 58 (07) :2103-2117
[7]   Combined use of Monte Carlo DNA damage Simulations and deterministic repair models to examine putative mechanisms of cell killing [J].
Carlson, David J. ;
Stewart, Robert D. ;
Semenenko, Vladimir A. ;
Sandison, George A. .
RADIATION RESEARCH, 2008, 169 (04) :447-459
[8]   Advantages and limitations of the 'worst case scenario' approach in IMPT treatment planning [J].
Casiraghi, M. ;
Albertini, F. ;
Lomax, A. J. .
PHYSICS IN MEDICINE AND BIOLOGY, 2013, 58 (05) :1323-1339
[9]   Hybrid 3D analytical linear energy transfer calculation algorithm based on precalculated data from Monte Carlo simulations [J].
Deng, Wei ;
Ding, Xiaoning ;
Younkin, James E. ;
Shen, Jiajian ;
Bues, Martin ;
Schild, Steven E. ;
Patel, Samir H. ;
Liu, Wei .
MEDICAL PHYSICS, 2020, 47 (02) :745-752
[10]   DOSE-VOLUME HISTOGRAMS [J].
DRZYMALA, RE ;
MOHAN, R ;
BREWSTER, L ;
CHU, J ;
GOITEIN, M ;
HARMS, W ;
URIE, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (01) :71-78